Genetic Biotechnology - Search News

Order byBest matchMost fresh

News

23andMe, Regeneron and genetic

23andMe, including sensitive genetic data, sold to biotech company Regeneron Pharmaceuticals

Announcing the $256 million deal, the New York-based biotech firm vowed to comply with 23andMe’s privacy policy, which was a condition of the sale. Genetic data was on the auction block, and a U.S. biotech company ponied up the cash.

Continue reading

· 3d · on MSN

· 2d · on MSN

Pharmaceutical company Regeneron buying 23andMe for $256 million

Regeneron to acquire human genetics company 23andMe for $256m

The American Bazaar2d

Biotech company Regeron to buy DNA tester 23andMe

In its announcement of the acquisition, Regeron claimed it would ensure that customers’ personal data including genetic and ...

KTVU FOX 2 on MSN3d

23andMe to be acquired by NY-based Regeneron in $256 million deal

The company, which was founded in 2006, rose to prominence by offering at-home DNA testing kits that allowed people to ...

3d

Biotech company to buy DNA testing site

A biotech company has announced plans to acquire 23andMe after the genetic testing company filed for Chapter 11 bankruptcy.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results